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Abstract
Increase prevalence of cardiovascular and other chronic diseases linked to inflammation
has led to research on pro-inflammatory cytokines, like tumor necrosis factor - alpha
(TNF-α) and lipoprotein-associated phospholipase A2 (Lp-PLA2), in attempt to define the
relationship between chronic disease, inflammation, and obesity. PURPOSE: Examine
the effect of twelve weeks of vigorous intensity interval training on pro-inflammatory
markers in post-operative bariatric and obese participants. METHODS: 9 post-operative
bariatric individuals [1 man, 8 women; Body mass index (BMI) = 34.23 ± 2.54 kg/m2],
12 obese individuals [5 men, 7 women; BMI=35.77 ± 1.67 kg/m2], and 13 obese
individuals [5 men, 8 women; BMI=39.69 ± 1.74 kg/m2] were assigned into three groups:
post-operative bariatric vigorous intensity interval training (PB-VIT), obese high
intensity interval training (OB-VIT), moderate intensity continuous training (MICT),
respectively. All groups underwent two weeks of familiarization on a treadmill
maintaining 50% age adjusted heart rate reserve (HRR) for 20 minutes. Weeks 3-6, VIT
performed 4 1-minute bouts at 80% HRR interspersed with 4 minutes at 50% HRR.
Whereas, MICT increased to 60% HRR. Weeks 7-12 VIT increased intensity to 50%
HRR for 3 minutes followed by 1 minute at 80% HRR for 6 rounds. MICT increased to
65% HRR for weeks 7-12. RESULTS: There were no significant changes from pre- to
post-training in TNF-α (p=0.115) or Lp-PLA2 (p=0.318). There was a significant
decrease in PB-VIT’s HDL (68.56 ± 20.00 vs. 59.89 ± 19.73; p=0.001). There were no
changes in LDL-C, triglycerides, Hb-A1c, or total cholesterol within the three groups.
Lean mass significantly increased in OB-VIT (56.82 ± 13.64 vs. 57.81 ± 13.34; p=0.006)
with a reduction in %BF (43.29 ± 9.49 vs. 42.41 ± 9.54; p=0.029). OB-MICT also had
v

significant reduction in %BF (47.23 ± 7.09 vs. 46.45 ± 6.99; p=0.008), but no change in
overall weight. No other significant changes were observed in body composition or
cardiorespiratory fitness. CONCLUSION: Vigorous interval training in post-operative
bariatric and obese individuals did not elicit significant changes in Lp-PLA2 and TNF-α
when performed 3 days a week for 12 weeks in response to either a moderate intensity
continuous exercise or VIT exercise protocol.
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Introduction
In 2017 the Centers for Disease Control and Prevention (CDC) reported
approximately 40% of adults in the United States suffered from obesity, defined as a BMI
≥30 kg/m2, with an upward trend between 1999-2000 and 2015-20161. The metabolic
complications associated with obesity contribute to increased systemic inflammation,
resulting in insulin resistance, dyslipidemia, and oxidative stress and ultimately an
increased risk of developing chronic diseases such as type 2 diabetes mellitus and
cardiovascular disease (CVD)2–5. According to the CDC, in 2016, 29% of deaths in the
United States were caused by CVD representing 635,000 mortalities, making it the
leading cause of death with rising new cases occurring each year6. The increase
prevalence of CVD and other chronic diseases linked to inflammation has led to research
on contributing pro-inflammatory cytokines, like tumor necrosis factor - alpha (TNF-α)
and lipoprotein-associated phospholipase A2 (Lp-PLA2), in an attempt to define the
relationship between chronic disease, inflammation, and obesity.
Lp-PLA2 is an enzyme of the phospholipase A2 family that circulates in the
plasma as a complex attached to high density lipoprotein cholesterol (HDL-C) and low
density lipoprotein cholesterol (LDL-C), with the majority attached to LDL-C7,8. As a
phospholipase, Lp-PLA2’s primary physiological responsibility is to release fatty acids
such as arachidonic acid from the cellular membrane lipids, phosphatidylethanolamine
and phosphatidylcholine. Arachidonic acid can then be metabolized into the signaling
molecules, eicosanoids, acting as local hormones; these molecules then impact the
digestive, reproductive, and pulmonary systems in addition to the blood vessels and
platelets of the cardiovascular system contributing to inflammation 9,10. Inflammatory
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cells including macrophages, monocytes, activated platelets, neutrophils, and mast cells,
secrete Lp-PLA2, with the highest level of secretion seen during the formation of
macrophages7.
Elevated Lp-PLA2 is found in tissue secretions and serum as a response to
inflammation, where it assists in the formation of lipid mediators involved with
inflammation9. In an environment with high oxidative stress, Lp-PLA2 hydrolyzes the
oxidized LDL-C (oxLDL) generating lysophosphatidylcholine and oxidized fatty acids,
two pro-inflammatory components that promote atherogenesis11. Oxidation of LDL-C
within the endothelium activates Lp-PLA2 to hydrolyze the structural phospholipids of
the cellular membranes encompassing macrophages and other cells11. This may
contribute to the destabilization of fibromuscular plaques12, increasing the risk of
myocardial infarction (MI)13 and ischemic stroke14. Therefore a reduction in Lp-PLA2
may be an indicator of reduced risk of developing CVD15.
TNF-α is an inflammatory cytokine produced by macrophages, monocytes,
smooth muscle cells, adipocytes, fibroblasts, and T-cells16. Responsible for the regulation
of immune cells leading to apoptosis, necrosis, inflammation, and cell proliferation, TNFα is found all over the body and can have both beneficial and detrimental effects. TNF-α
is released in response to the consumption of oxidized LDL-C by macrophages causing
the activation of T-lymphocytes. Once activated, T-lymphocytes will release more TNFα leading to an increase in number of adhesion molecules on the endothelial cells (i.e.
inflammation). Excess levels of TNF- α increases CVD risk by exacerbating the
inflammatory response as well as promoting the formation of fatty streaks and lesions
responsible for the narrowing of arteries indicative of atherosclerosis7. Extended elevated
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TNF-α levels has been linked to chronic inflammation, atherogenesis, insulin resistance
and impairment of lipid metabolism7,16,17.
Obesity increases inflammation, blood pressure, insulin resistance, dyslipidemia,
and many other factors18,19. It also increases the risk of developing chronic diseases like
diabetes, metabolic syndrome, musculoskeletal problems, some forms of cancers, and
CVD18. Research has found increased levels of Lp-PLA220 and TNF- α21,22 in obese
individuals when compared to individuals with normal BMI. A reduction in excess
adipose tissue, can contribute to a decreased risk of developing chronic conditions by
decreasing inflammatory markers and returning blood lipids and insulin response to
normal levels23,24. Methods of adipose tissue reduction include: surgery, lifestyle change
by diet and exercise, or a combination of both19.
Bariatric surgery is a common method to aid in the reduction of adipose tissue by
surgically altering or restricting the stomach and/or intestines19,25. According to the
American Society for Metabolic and Bariatric Surgery, bariatric surgery is appropriate for
individuals with a BMI ≥ 40 kg/m2 or more than 100 pounds overweight, unsuccessful
weight loss via nonsurgical means, and/or a BMI ≥ 35 kg/m2 with at least one or more
obesity-related comorbidities26. Bariatric surgery routinely results in ~60% decrease in
visceral fat and ~50% reduction in whole body fat mass27. The substantial weight loss
associated with bariatric surgery rapidly improves insulin sensitivity, glycemic
regulation, and lipid profile27. The improvement in insulin sensitivity and glycemic
control is largely due to the improvement in hepatic insulin sensitivity and beta cell
functioning27. Substantial reduction in adipose tissue yields a decrease in triglycerides,
LDL-C particle number, decreased proportion of small particle LDL-C, and an increase
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in HDL-C19. In addition to a reduction in adipose tissue, research shows that bariatric
surgery can reduce the levels of oxLDL and Lp-PLA228 with no significant long term
sustained reduction in TNF- α up to 12 months post-surgery19,29–32.
Surgery can be used in cases of uncontrolled obesity; however, it should be used
as one component to a healthier way of living. By combining lifestyle interventions, like
exercise and diet, they can maximize physiological functions (i.e. fat metabolism, insulin
sensitivity, etc.) and reduce the common occurrence of weight regain26,27. Chaston et al
reported a 31.3% reduction in weight due to loss of fat free mass after Roux-en-Y gastric
bypass surgery (RYGB),33 this in turn can lower their basal metabolic rate, increasing
their likelihood of regaining weight27. A study by Faria et al examined the energy
expenditure and weight regain of individuals’ post-RYGB surgery and determined the
weight regain group had a lower basal metabolic rate than the healthy weight postoperative group34. For this reason, it is recommended to supplement surgery with diet and
exercise to build lean muscle mass, increasing and/or sustaining basal metabolic rate to
avoid weight regain.
Post-operative bariatric individuals are capable of participating in exercise
programs with benefits seen in insulin resistance35, cardiorespiratory fitness and body
composition36–38. Greater reduction in fat mass and improvements in cardiorespiratory
function have been found in individuals exercising post-surgery when compared to those
that solely receive post-surgery “usual care”39,40. However, a study by Afshar et al.,
reported no significant difference in physical activity pre vs post-surgery41 which may
account for the likelihood of weight regain. Contributing barriers to exercise in the postoperative bariatric population, reported by Gill et al., included: self-doubt, time, and lack
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of motivation42. Similar barriers were reported in the obese population with lack of
motivation being the primary barrier followed by work schedule then disability/health
problems43. This research suggests that surgery doesn’t change or fix common barriers to
exercise. Therefore, addressing barriers within a training program may elicit a greater
adherence to exercise for both obese and post-operative bariatric populations, and
therefore better overall outcomes post-surgically.
The barrier of time is one of the leading reasons why high intensity interval
training (HIIT) has become popular over the past decade44. As a consequence of
performing high intensity training through intervals, individuals are able to elicit the
benefits of exercise within a shorter period of time. HIIT has been used in several
different populations, including obese, with beneficial results found in body
composition45,46, cardiorespiratory fitness47,48, lipid profiles49–52, glucose51, insulin
regulation53, and perceived enjoyment54,55. However, HIIT has not been utilized in the
post-operative bariatric population, therefore the efficacy and viability in this population
remain unknown.
In addition to the known improvements in body composition, cardiorespiratory
fitness, lipid profiles, and insulin sensitivity, exercise has been linked to a possible
decrease in inflammatory markers56. In association with weight loss, significant
reductions in Lp-PLA224 and TNF-α57,58 have been reported after continuous aerobic
exercise training with improvements seen as early as 6 and 4 weeks, respectively.
Reductions in Lp-PLA2 may be dependent on lifestyle modifications associated with
weight loss without lipid therapy59; however, TNF-α can be reduced in absence of weight
loss as shown by Koh and Santos et al57,58. Both studies had participants undergo
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continuous aerobic exercise training and reported a decrease in TNF-α with as few
sessions as 3 days per week for 4 weeks57,58. In contradiction to these finding, a study by
Friedenreich et al, followed 320 postmenopausal women for 1 year of supervised
continuous aerobic training 5 days per week and found no significant change in TNF-α
without weight loss60. Therefore, the pro-inflammatory cytokines, Lp-PLA2 and TNF-α,
may be more inclined to significant reduction when exercise is associated with weight
loss. As seen in in studies on HIIT and obese participants, weight loss is a frequent result
of training45,46; therefore, HIIT may result in decreased Lp-PLA2 and TNF-α in obese and
post-operative bariatric participants.
The inflammatory cytokines, Lp-PLA2 and TNF-α, have not been researched
during aerobic vigorous interval training in either obese or post-operative bariatric
participants; therefore, the purpose of the current study is to determine if 12-week
vigorous interval training affects pro-inflammatory markers in obese and post-operative
bariatric participants. The hypothesis is that 12 weeks of vigorous interval training will
reduce pro-inflammatory markers (Lp-PLA2 and TNF- α) in post-operative bariatric and
obese participants and that these reductions may be mediated by weight loss.
Assumptions/Limitations/Delimitations
The assumption is that an exercise will reduce adipose tissue in previously
sedentary people. Some possible limitations include: the participants not being physically
capable of reaching vigorous intensity, psychological barriers, time restrictions,
adherence, and potential issues with equipment. To reduce the limitations, this study will
screen individuals and receive physician’s approval for all post-operative bariatric
participants.
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Methods
Study Design
Obese and post-operative bariatric surgery participants will be recruited to participate in
12 weeks of exercise training 3 days per week at James Madison University. Prior to
participation, all participants will complete an informed consent, the Physical Activity
Readiness Questionnaire (PAR-Q), Health Status Questionnaire, and receive physician’s
approval when indicated before the beginning of the study. Participants will be assigned
to either vigorous intensity interval (VIT) or moderate intensity continuous training
(MICT). Clinical and fitness evaluations will be performed at baseline, midway, and
post-intervention (Figure 1). All procedures will be approved through the James Madison
University Institutional Review Board.
Participants
Adult participants will be recruited through Sentara RMH Weight Loss Surgery Medical
Center (SRMH) and James Madison community via bulk email. A total of 15 postoperative bariatric and 33 obese participants will be assigned to the three different
groups. The 15 post-operative bariatric participants will be assigned to the VIT (PB-VIT),
18 obese to MICT (OB-MICT), and 15 obese to VIT (OB-VIT). Inclusion criteria for the
post-operative bariatric population 6-24 months post-surgery and the obese population
(OB) BMI ≥30 kg/m2. Exclusion criteria for both populations include orthopedic
limitations that would limit their ability to complete the exercise intervention, women
who are pregnant, or health conditions that would place them at high risk according to
ACSM guidelines61.
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Clinical Measurements
Blood Analysis
Clinical measurements will be performed in the Health Assessment Lab. Fasted (8-10
hours) blood samples will be obtained via venipuncture of the antecubital vein by a
certified phlebotomist. Immediately after collection of blood, vials will be inverted three
times and rested at room temperature for 30 mins before being spun in the EBA 21
centrifuge (Andreas Hettich GmbH & Co., Tuttlingen, Germany) at a spin speed of 5000
for 11 min. Serum will be pipetted in 2 mL tubes and immediately frozen in a So-Low
Ultra-Low Freezer (Environmental Equipment, Cincinnati, OH) at -85℃ until analysis.
Blood samples will be analyzed, in duplicate, using the ChemWell 2910 (Awareness
Technology Inc., Palm City, FL), using chemical reagent manufacturer instructions to
determine total cholesterol, LDL-C, HDL-C, and triglycerides (Randox Laboratories,
Kearneysville, WV). Analysis of Lp-PLA2 (RayBiotec, Peachtree Corners, GA), TNF-α
(R and D Systems, Minneapolis, MN), Lipoprotein (a) (Abcam, Cambridge UK), and
glucose (Invitrogen, Carlsbad, CA) will be performed by an independent laboratory
(Virginia Tech Metabolic Phenotyping Core, Blacksburg, VA). Hemoglobin A1c
(HbA1C) will be determined using the SIEMENS DCA Vantage (Siemens Healthcare
Diagnostics Inc., Tarrytown, NY) via finger stick.
Body Composition
Weight and height will be obtained using the MedVue Detecto MV1 scale. Waist-to-hip
ratio will be calculated by dividing the measured waist circumference, defined as the
narrowest part of between the xiphoid process and naval, by the hip circumference,
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defined as the widest part of the hips using a Gulick tape measure61 (Creative Health
Products, Ann Arbor, MI). Body composition will be measured by a trained technician
using dual-energy x-ray absorptiometry (DEXA) for a total body scan. The assessment
will be performed using the Norland Bone Densitometer Elite (Swissray International,
Inc., Piscataway, NJ). Resting blood pressure will be measured using a stethoscope and a
sphygmomanometer on the left arm while the participant is in the supine position
following the DEXA scan.
Fitness Measurements
Participants will undergo a symptom limited submaximal graded exercise test on
a Tuff Tread treadmill (Conroe, TX) using the Modified Balke protocol while connected
to the ParvoMedics TrueOne 2400 Metabolic System Model DCM2400 (Sandy, Utah) to
obtain VO2 values. Speed and/or grade will be increased each stage with blood pressure,
rate of perceived exertion (RPE) using Borg Rating of Perceived Exertion Scale, and
heart rate being monitored. Participants will wear the Polar H3 heart rate sensor strap
(Lake Success, NY) to measure heart rate shown on Polar RS800CX (Lake Success, NY)
training computer for the duration of the test. The test will be terminated if the participant
reaches 80-85% of age-predicted heart rate max, experience adverse signs and symptoms,
volitional fatigue, or ask to stop61.
Exercise Intervention
Participants will undergo 12 weeks of exercise intervention on either a Life
Fitness 95Ti Integrity Treadmill (Franklin Park, IL) or StairMaster ClubTrack612
Treadmill (Kirkland, WA) 3 times per week. Participants will start each session by
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receiving a Polar T31-CODED (Lake Success, NY) transmitter heart rate strap and Polar
FT1 (Lake Success, NY) watch. Once resting heart rate (HR) is obtained, heart rate
reserve (HRR) will be calculated using age-predicted heart rate max, resting HR, and the
prescribed percent intensity, shown in Figure 2. HRR will be used to determine percent
intensity to ensure that the VIT groups achieve high intensity intervals and the OB-MICT
maintains a continuous intensity for the duration of the study. The participants will warm
up with 5 min of dynamic exercise (leg swings, calf raises, wall pushups, marching in
place, stability ball wall squats) followed by a 5 min walking warm up on the treadmill.
All groups will complete exercise at 50% HRR for 20 min their first two weeks
for familiarization. As shown in Figure 2, weeks 3-6, both VIT groups will begin
intervals at 50% HRR for 4 min followed by 1 min at 80% HRR for 4 times. Weeks 7-12,
will decrease time at 50% HRR to 3 min for 6 times followed by 1 min at 80% HRR.
Weeks 3-6, MICT, will increase intensity to 60% HRR for 20 min and 65% HRR for 20
min for Weeks 7-12. HR, speed, grade, and RPE will be obtained every other stage for
OB-MICT and every stage for both VIT groups. Upon the completion of the exercise, the
participants will walk on the treadmill for an additional five minutes followed by a 5 min
light stretching protocol to cool down. The participants will be required to exercise at
least 85% of the sessions for study benefits and to remain in study.
Statistical Analysis
Analyses will be performed with IBM SPSS version 24 (Armonk, NY). Statistics
will consist of mixed-design ANOVA (time x exercise condition), followed by post-hoc
tests with a least squares difference correlation factor. Bivariate analyses and linear
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regressions will also be used to assess the relationships between variables. A p < 0.05
was considered statically significant, a priori.
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12 weeks of vigorous interval training is insufficient to alter Lp-PLA2 and TNF-α in
post-operative bariatric and obese participants
In 2017 the Centers for Disease Control and Prevention (CDC) reported
approximately 40% of adults in the United States suffered from obesity, defined as a BMI
≥30 kg/m2, with an upward trend between 1999-2000 and 2015-2016.1 The metabolic
complications associated with obesity contribute to increased systemic inflammation,
resulting in insulin resistance, dyslipidemia, and oxidative stress and ultimately an
increased risk of developing chronic diseases such as type 2 diabetes mellitus and
cardiovascular disease (CVD).2–5 The increase prevalence of CVD and other chronic
diseases linked to inflammation has led to research on contributing pro-inflammatory
cytokines, like tumor necrosis factor - alpha (TNF-α) and lipoprotein-associated
phospholipase A2 (Lp-PLA2), in an attempt to define the relationship between chronic
disease, inflammation, and obesity. Specifically, increased levels of Lp-PLA2 has been
linked to an elevated risk of CVD and may contribute to the destabilization of
fibromuscular plaques.6 Therefore a reduction in Lp-PLA2 may be an indicator of
reduced risk of developing CVD7. Increased levels of TNF-α8,9 and Lp-PLA2 10 have been
found in obese individuals when compared to individuals with a normal BMI. A
reduction in excess adipose tissue can contribute to a decreased risk of developing
chronic conditions by decreasing inflammatory markers and returning blood lipids and
insulin response to normal levels.11,12 Methods of adipose tissue reduction include
surgery, lifestyle change by diet and exercise, or a combination of both.13
Bariatric surgery is a common method to aid in the reduction of adipose tissue by
surgically altering or restricting the stomach and/or intestines. Surgery may be used as
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one aspect of a multi-disciplinary approach to improve health. Lifestyle interventions,
such as exercise and diet, can maximize improvement in physiological function (i.e. fat
metabolism, insulin sensitivity, etc.) and reduce the common occurrence of weight
regain.14,15 Chaston et al. reported 31.3% of reduction in weight due to loss of fat free
mass (skeletal muscle, bone, and organs) after Roux-en-Y gastric bypass surgery
(RYGB),16 this, in turn, can lower their basal metabolic rate, increasing their likelihood
of weight regain.15 For this reason, it is recommended to supplement surgery with diet
and exercise to build lean muscle mass, sustaining and/or increasing basal metabolic rate
to avoid weight regain. When compared to those that solely received “usual care” postbariatric surgery, the post-surgery individuals that participated in exercise programs had
greater reductions in fat mass and improvements in cardiorespiratory fitness.17,18
Contributing barriers to exercise in the post-operative bariatric population,
reported by Gill et al., included: self-doubt, time, and lack of motivation.19 The barrier of
time is one of the leading reasons why high intensity interval training (HIIT) has become
popular over the past decade.20 HIIT has been used in several different populations,
including obese, with beneficial results found in body composition21,22, cardiorespiratory
fitness23,24, lipid profiles25–28, glucose27, insulin regulation29, and perceived
enjoyment.30,31 However, HIIT has not been utilized in the post-operative bariatric
population, therefore the efficacy and viability in this population remain unknown.
In addition to the known improvements in body composition, cardiorespiratory
fitness, lipid profiles, and insulin sensitivity, exercise has been linked to a possible
decrease in inflammatory markers.32 In association with weight loss, significant
reductions in Lp-PLA212 and TNF-α33,34 have been reported after continuous aerobic
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exercise training with improvements seen as early as 6 and 4 weeks, respectively.
Reductions in Lp-PLA2 may be dependent on lifestyle modifications associated with
weight loss without lipid therapy35; however, TNF-α can be reduced in absence of weight
loss as shown by Koh and Santos et al.33,34 Both studies had participants undergo
continuous aerobic exercise training and reported a decrease in TNF-α with as few
sessions as 3 days per week for 4 weeks.33,34 In contradiction to these findings, a study by
Friedenreich et al., followed 320 postmenopausal women for 1 year of supervised
continuous aerobic training 5 days per week and found no significant change in TNF-α
without weight loss.36 Therefore, the pro-inflammatory cytokines, Lp-PLA2 and TNF-α,
may be more inclined to significant reduction when exercise is associated with weight
loss. As seen in studies on high intensity interval training (HIIT) and obese participants,
weight loss is a frequent result of training21,22; therefore, HIIT may result in decreased
Lp-PLA2 and TNF-α in obese and post-operative bariatric participants.
The inflammatory cytokines, Lp-PLA2 and TNF-α, have not been researched
during aerobic vigorous interval training in either obese or post-operative bariatric
participants; therefore, the purpose of the current study is to determine if 12-week
vigorous interval training affects pro-inflammatory markers in obese and post-operative
bariatric participants. The hypothesis is that 12 weeks of vigorous interval training will
reduce pro-inflammatory markers (Lp-PLA2 and TNF- α) in post-operative bariatric and
obese participants and that these reductions may be mediated by weight loss.
Methods
Study Design
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Obese and post-operative bariatric surgery participants were recruited to participate in 12
weeks of exercise training 3 days per week at James Madison University. Before
participation, all participants completed an informed consent, the Physical Activity
Readiness Questionnaire (PAR-Q), a Health Status Questionnaire, and received
physician’s approval when indicated before the beginning of the study. Participants were
assigned to either vigorous intensity interval (VIT) or moderate intensity continuous
training (MICT). Clinical and fitness evaluations were performed at baseline, midway,
and post-intervention (Figure 1). All procedures were approved through the James
Madison University Institutional Review Board.
Participants
Post-operative bariatric participants were recruited through Sentara RMH Weight Loss
Surgery Medical Center (SRMH) and obese participants were recruited via bulk email
through the James Madison community. A total of 15 post-operative bariatric and 33
obese adult participants were assigned to the three different groups. The 15 postoperative bariatric participants were assigned to the VIT (PB-VIT), 18 obese to MICT
(OB-MICT), and 15 obese to VIT (OB-VIT). Inclusion criteria for the post-operative
bariatric population 6-24 months post-surgery and the obese population (OB) BMI ≥30
kg/m2. Exclusion criteria for both populations included orthopedic limitations that would
limit their ability to complete the exercise intervention, women who were pregnant, or
health conditions that would place them at high risk according to ACSM guidelines.37
Clinical Measurements
Blood Analysis
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Clinical measurements were performed in the Health Assessment Lab. Fasted (8-10
hours) blood samples were obtained via venipuncture of the antecubital vein by a
certified phlebotomist. Immediately after collection of blood, vials were inverted three
times and rested at room temperature for 30 mins before being spun in the EBA 21
centrifuge (Andreas Hettich GmbH & Co., Tuttlingen, Germany) at a spin speed of 5000
for 11 min. Serum was pipetted in 2 mL tubes and immediately frozen in a So-Low UltraLow Freezer (Environmental Equipment, Cincinnati, OH) at -85℃ until analysis. Blood
samples were analyzed, in duplicate, using the ChemWell 2910 (Awareness Technology
Inc., Palm City, FL), using chemical reagent manufacturer instructions to determine total
cholesterol, LDL-C, HDL-C, and triglycerides (Randox Laboratories, Kearneysville,
WV). Analysis of Lp-PLA2 (RayBiotec, Peachtree Corners, GA), TNF-α (R and D
Systems, Minneapolis, MN), Lipoprotein (a) (Abcam, Cambridge UK), and glucose
(Invitrogen, Carlsbad, CA) were performed by an independent laboratory (Virginia Tech
Metabolic Phenotyping Core, Blacksburg, VA). Hemoglobin A1c (HbA1C) was
determined using the SIEMENS DCA Vantage (Siemens Healthcare Diagnostics Inc.,
Tarrytown, NY) via finger stick.
Body Composition
Height and weight (MedVue Detecto MV1, Cardinal Detecto, Webb City, MO) were
assessed to calculate BMI. Additionally, waist and hip circumference, body fat
percentage, lean body mass, and fat mass (DXA, Norland Swissray International, Inc.,
Piscataway, NJ) were assessed as measures of body composition.
Blood pressure
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Blood pressure was assessed in the supine position manually following the DXA scan.
Fitness Measurements
Participants underwent a symptom-limited submaximal graded exercise test on a
treadmill using the Modified Balke protocol. Participants’ heart rates were monitored
throughout the test by a Polar H3 heart rate sensor strap (Lake Success, NY) and Polar
RS800CX (Lake Success, NY) training computer. Blood pressure and rate of perceived
exertion were also recorded for the duration of the test. End criteria included: participant
reached 80-85% of age-predicted heart rate max, experienced adverse signs and
symptoms, volitional fatigue, or asked to stop.37
Exercise Intervention
Participants underwent 12 weeks of a supervised exercise intervention on a
treadmill 3 times per week. Heart rate monitors were utilized throughout each exercise
session to ensure adherence to the exercise protocol. Heart rate reserve (HRR) was used
to prescribe exercise intensity.
Each exercise session began with a 5-minute dynamic warm-up. Following a
common two-week run-in period, the exercise protocols began differing in week 3
(Figure 2). Exercise protocols were designed to match total volume. The participants
were required to exercise at least 85% of the sessions to receive study incentives and to
remain in the study.
Statistical Analysis
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Analyses were performed with IBM SPSS version 25 (Armonk, NY). Statistics
consisted of mixed-design ANOVA (time x exercise condition), followed by post-hoc
tests utilizing a least squares difference correction factor. Bivariate analyses and linear
regressions were also used to assess the relationships between variables. Statistical
significance was established a priori as p < 0.05.
Results
15 post-bariatric participants and 33 obese participants volunteered to participate
in the study. All post-bariatric participants were assigned to the VIT protocol (PB-VIT),
while obese participants were assigned to either the VIT protocol (n=15, OB-VIT) or a
MICT (OB-MICT) protocol (n=18). A total of 14 subjects, 6 from PB-VIT, 3 from OBVIT, and 5 from OB-MICT dropped the study, with reasons including lack of time,
illness, injury not pertaining to the study, and not being able to adhere to intensity
protocol. PB-VIT participants had significantly lower weight (p=0.015) and BMI (p =
0.042) at baseline than the participants assigned to the OB-MICT group (Table 1). No
other differences existed in baseline demographics. Similarly, there were no significant
differences at baseline among participants who completed the study and those who
dropped out.
After 12-weeks of training, there were no significant changes from pre- to posttraining in TNF-a (p=0.115; Figure 1) or Lp-PLA2 (p=0.318; Figure 2). There was a
significant decrease in PB-VIT’s HDL (p=0.001; Table 2). However, there were no
changes in LDL-C, triglycerides, Hb-A1c, or total cholesterol (Table 2) within the three
different groups. Lean mass significantly increased in the OB-VIT group (p=0.006;
Table 2) with a reduction in %BF (p=0.029; Table 2). OB-MICT also had a significant
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reduction in %BF (p=0.008), but no change in overall weight. No other significant
changes were observed in body composition or cardiorespiratory fitness (VO2max; Table
2).
Discussion
This study found the pro-inflammatory cytokines Lp-PLA2 and TNF-α did not
change after 12 weeks of exercise training. The lack of change in Lp-PLA2 and TNF-α
was surprising based on the findings of Buyukyazi et. al. and Koh et. al., respectively.12,33
Our findings may be related to the lower total volume of exercise and/or the lack of
change in weight. While no group demonstrated a significant change in weight, both
obese groups demonstrated improvements in body composition, however, there was no
accompanying change in inflammatory markers.
Lp-PLA2
The failure of the groups to decrease in Lp-PLA2 values after the intervention was
unexpected based on previous literature. A study by Buyukyazi et al., in premenopausal
women demonstrated significant reductions in Lp-PLA2 following both the vigorous (7075% HRR) and moderate(50-55% HRR) walking intervention after 12 weeks, 5 days
per week starting at 30 minute durations and increasing by 3 minutes until 60 minutes
was achieved in week 12.12 Participants in this study demonstrated a significant mean
reduction in both weight (2.45 kg) and Lp-PLA2. Similarly, Zlatohlavek examined the
impact of physical activity on Lp-PLA2 in obese children ranging from 9 to 16 years.11
They found a significant reduction in Lp-PLA2 measurements after 1 month of training 5
times a day for 50 minutes per session (including both resistance and aerobic exercises)
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paired with caloric supervision, resulting in an average weight loss of 6.37 kg. These
studies suggest that either a greater frequency, longer exercise bout duration, or weight
loss are required to successfully alter Lp-PLA2 through an exercise intervention.
TNF-α
TNF-α has previously been found to decline following aerobic training of as little
as 3 d/wk, 60 min/d for 4 weeks33 or 3 d/wk, 30-45 min/d, for 6 weeks38, while 2 weeks
of 3 days per week, 40 min per day was found to be insufficient.39 The majority of studies
on obese or overweight individuals, particularly women, saw a reduction with or without
a decrease in weight or change in body composition making the findings of the current
study surprising.
Koh et al. reported a significant reduction in TNF-α in the population after only 4
weeks of walking 3 days a week for 60 min at moderate intensity with no change in
weight, fat mass, or BMI.33 Alternatively, studies by Polak and Friedenreich et al. found
no significant change in TNF-α without weight loss in studies lasting 12 weeks and 1
year of continuous aerobic exercise, respectively.36,40 These studies suggest that there
can be a significant decrease in TNF-α after exercise and may indicate that a greater
frequency (4 or more days per week) and/or total exercise volume must be achieved to
elicit significant changes. Further research is required to definitively determine if exercise
can cause reductions in TNF-α in the absence of changes in overall weight and body
composition.
HIIT’s impact on TNF-α remains to be well understood. However, a study by
Gerosa-Neto et al. had 32 obese/overweight men and women perform 16 weeks of HIIT 3
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days a week. The HIIT protocol in this study involved 4 bouts of 4 minutes at 90%
HRmax, yielding a greater overall volume than the current study. While subjects had a
similar starting weight and BMI as the present PB-VIT group, the Gerosa-Neto study
reported an increase in TNF-α, with no significant reduction in weight.41 This may
indicate that certain HIIT protocols may induce increases in TNF-α, although the protocol
utilized in the present study did not elicit changes in either direction for TNF-α.
Body Composition, Lipids, Fitness
Overall, changes in body composition, lipids, and fitness measurements were
limited as a result of the training protocols. Significant reductions in percent body fat
were seen in both OB-MICT and OB-VIT with an increase in lean mass only seen in the
OB-VIT group. However, improvements in body composition were expected for all
groups based on the current research. Zhang et al. found after 12 weeks of HIIT (4:3 min
at 90% VO2max) or MICT (60% VO2max) on a cycle ergometer, 3-4 days per week, yielded
similar improvements in whole-body and regional fat mass as well as VO2max between
groups22. Similarly, Fisher et al. examined the differences between HIIT and MICT on a
cycle ergometer in obese males and reported reduced blood lipids, improved body
composition, and improved cardiovascular fitness after 6 weeks of training25.
Hassannejad et al. reported significant improvements in body composition and
cardiorespiratory fitness after only 12 weeks of walking at a moderate intensity for 3-5
d/wk post-operative bariatric surgery42. Weeks 1-4 encouraged 150 min/wk of walking
with an increase to 150-200 min/wk. These studies reported a significant change at higher
exercise volume protocols than the current study, possibly explaining the difference in
findings.
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Keating et al. had a similar volume of exercise found in the current study’s VIT
program after cycling 3 days per week with 4 bouts of intervals 30-45 s at 120% VO2peak
followed by 120-180 s at low intensity for the first 4 weeks with an increase to 6 intervals
at a work:rest ratio of 60:120 seconds for the remaining 8 weeks.43 The similar absence of
improvement in overall body composition and lipids may support the need for a larger
training volume to elicit a change.
Practical Application
Cardiovascular disease is the most common cause of death in the United States.
Proinflammatory blood markers, like Lp-PLA2 and TNF-α, contribute to the rupturing of
plaques and atherosclerosis. Therefore, the reduction of these can aid in lowering the risk
and prevalence of cardiovascular disease. This study revealed that vigorous interval
training with this frequency, duration, and intensity may be inadequate to elicit
meaningful change in Lp-PLA2 and TNF-α in the absence of weight loss and
improvement of body composition; however, more research is needed. Increasing
frequency, and/or pairing exercise with calorie control, may aid in the reduction of LpPLA2 and TNF-α, possibly contributing to the decreased risk of cardiovascular disease in
the post-operative bariatric and obese populations.
Limitations
The study had several limitations, most notably its high drop-out rate, resulting in
relatively small intervention groups. While activity outside the intervention was not
controlled, all participants were instructed to continue physical activity and eating habits
as usual. Also, the post-operative bariatric group received lifestyle change information
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before and after surgery to aid in their reduction of adipose tissue, whereas the
participation in education programs for the other groups was unknown. Future research
can include increasing the frequency of exercise and decreasing the number of total
weeks.
Summary
Vigorous interval training in post-operative bariatric and obese individuals did not
elicit significant changes in Lp-PLA2 and TNF-α when performed 3 days a week for 12
weeks in response to either a moderate intensity continuous exercise or a VIT exercise
protocol. Areas for future research would be to conduct this experiment with a larger
sample size with a greater volume to cause an improvement in body composition and
weight. This may elicit the anticipated training effect of decreased pro-inflammatory
markers in the groups.
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Figure 1: 15-week timeline including baseline, mid-, post-clinical and fitness assessment
weeks in addition to 12 weeks of training.

Figure 2: Exercise intervention intensity progression for vigorous intensity interval and
moderate intensity continuous training.
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Table 1: Baseline demographic measurements of participants. Data are presented as
means ± standard error of mean.
PB-VIT (n=15)

OB-VIT (n=15)

OB-MICT (n=18)

46.53±2.75

39.93±2.65

44.61±2.80

1/14

6/9

7/11

Height (in)

65.92±0.88

67.97±1.24

68.04±0.98

Weight (lb)

204.04±14.56

230.49±9.03

255.06±12.57*

%Body Fat

42.85±2.03

43.46±2.24

47.85±1.92

BMI (kg/m2)

33.89±2.06

36.44±1.47

39.84±1.45*

Waist to Hip Ratio

0.82 ± 0.02

0.84 ± 0.02

0.87 ± 0.03

Waist Circumference

94.15 ± 4.96

100 ± 2.99

107.41 ± 3.39

Age (years)
Males /Females

(in)
* Significantly different than PB-VIT (p<0.05)
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Figure 3: Comparison of mean Lp-PLA2 (ng/mL) values between training groups and
obese moderate intensity continuous before and after exercise.
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Figure 4: Comparison of mean TNF-α (pg/mL) values between training groups and obese
moderate intensity continuous before and after exercise.
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Table 2: Comparison of pre- and post- blood and fitness measurements. Data are
presented as mean values ± standard deviation.
PB-VIT (n=9)
Pre
Weight (lb)
Systolic Blood
Pressure (mmHg)
Diastolic Blood
Pressure (mmHg)

Post

OB-VIT (n=12)
Pre

Post

MICT (n=13)
Pre

Post

205 ± 59.95

206.44 ± 61.30

227.22 ± 38.42

225.97 ± 38.94

250.96 ± 56.30

250.31 ± 54.46

120.78 ± 10.04

126.22 ± 13.47

118.18 ± 5.34

118.08 ± 2.58

125.92 ± 9.54

128.62 ± 9.57

77.56 ± 11.69

78.89 ± 9.49

74.91 ± 6.11

78.50 ± 4.01

82.31 ± 6.01

82.62 ± 3.86

Body Fat (%)

44.63 ± 6.60

43.64 ± 8.25

43.29 ± 9.49

42.41 ± 9.54*

47.23 ± 7.09

46.45 ± 6.99*

Fat Mass (kg)

43.67 ± 15.97

44.04 ± 16.06

45.45 ± 14.51

45.24 ± 15.02*

55.98 ± 16.13

55.61 ± 16.36

Lean Mass (kg)

50.15 ± 15.01

50.37 ± 15.31

56.82 ± 13.64

57.81 ± 13.34*

59.09 ± 14.01

59.74 ± 13.29

34.23 ± 7.63

34.45 ± 7.85

35.77 ± 5.80

35.56 ± 5.82

39.69 ± 6.28

39.60 ± 5.96

5.32 ± 0.28

5.53 ± 0.40

5.53 ± 0.36

5.46 ± 0.47

5.82 ± 0.77

5.53 ± 0.88

LDL

134.53 ± 41.84

135.47 ± 38.75

136.96 ± 44.14

130.49 ± 49.97

124.45 ± 45.77

133.44 ± 32.24

HDL

68.56 ± 20.00

59.89 ± 19.73*

55.42 ± 15.61

55.25 ± 16.54

46.69 ± 11.56

45.77 ± 10.18

162.33 ± 132.94

107.33 ± 49.90

113.67 ± 77.86

92.33 ± 36.84

138.77 ± 95.38

148.00 ± 91.58

235.56 ± 40.23

195.17 ± 81.35

215.11 ± 54.63

204.21 ± 56.30

168.19 ± 87.57

208.81 ± 29.33

23.98 ± 5.23

26.04 ± 3.73

25.74 ± 6.27

27.16 ± 9.83

26.13 ± 6.01

26.32 ± 4.91

2

BMI (kg/m )
HbA1c

Total Triglycerides
Cholesterol
VO2max

*p<0.05 pre to post
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Appendix
James Madison University
Human Research Review Request
Exempt:
Expedited:
Full Board:

FOR IRB USE ONLY:
Protocol Number:171st Review:
0571
IRB:
2nd Review:
3 Review:

Improving Health Outcomes in Obese Individuals Through Additional
Nutrition and Exercise Support
From:
06/01/17

Project Dates:

MM/DD/YY

(Not to exceed 1 year minus 1 day)

Responsible
Researcher(s):
E-mail Address:
Telephone:
Department:
Address (MSC):
Please Select:

Reviewer:

rd

Received:

Project Title:

Reviewer:

05/31/18
MM/DD/YY

Jeremy D. Akers, Elizabeth S. Edwards, David L. Wenos, Trent A. Hargens,
DJ Velky, Kristen Byrne, Brittany Rood
akersjd@jmu.edu, edwardes@jmu.edu
88974
Health Sciences/ Kinesiology
4301
Faculty
Administrator/Staff Member

Undergraduate Student
Graduate Student

(if Applicable):
Research Advisor:
E-mail Address:
Telephone:
Department:
Address (MSC):
Minimum # of Participants:

15

Maximum # of Participants:

60

Funding:

Incentives:

External Funding:

Yes:

No:

Internal Funding:

Yes:

No:

Independently:
Yes:
No:
Will monetary incentives be offered? Yes:
No:
Participants that are
in the Nutrition Intervention will receive $25/week vouchers to the Harrisonburg
Farmer’s Market. Participants who successfully both interventions will receive
new fitbits.
If yes: How much per recipient?

Must follow JMU Financial Policy:

If yes, Sponsor: Sentara RMH
Handled through SRMH
If yes, Sponsor: Submitted grant
to CHBS

In what form?

http://www.jmu.edu/financemanual/procedures/4205.shtml#.394IRBApprovedResearchSubjects
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Institutional Biosafety
Committee
Review/Approval:

Will research be conducted
outside of the United
States?

Certain vulnerable
populations are afforded
additional protections
under the federal
regulations. Do human
participants who are
involved in the proposed
study include any of the
following special
populations?
Some populations may be
vulnerable to coercion or
undue influence. Does your
research involve any of the
following populations?

Use of recombinant DNA and synthetic nucleic acid molecule research:
Yes
No
If “Yes,” approval received:
Yes
No
Pending
IBC Protocol Number(s):
Biosafety Level(s):
Yes
No
If “Yes,” please complete and submit the International Research Form
along with this review application:
http://www.jmu.edu/researchintegrity/irb/forms/irbinternationalresearch.docx.

Minors
Pregnant women (Do not check unless you are specifically recruiting)
Prisoners
Fetuses
My research does not involve any of these populations
Elderly
Diminished capacity/Impaired decision-making ability
Economically disadvantaged
Other protected or potentially vulnerable population (e.g. homeless, HIVpositive participants, terminally or seriously ill, etc.)
My research does not involve any of these populations

Investigator: Please respond to the questions below. The IRB will utilize your responses to evaluate your
protocol submission.
1.

YES

NO Does the James Madison University Institutional Review Board define the project as
research?

The James Madison University IRB defines "research" as a "systematic investigation designed to develop or contribute to generalizable
knowledge.” All research involving human participants conducted by James Madison University faculty and staff and students is
subject to IRB review.

2.

YES

NO Are the human participants in your study living individuals?

“Individuals whose physiologic or behavioral characteristics and responses are the object of study in a research project. Under the
federal regulations, human subjects are defined as: living individual(s) about whom an investigator conducting research obtains:
(1) data through intervention or interaction with the individual; or (2) identifiable private information.”

3.

YES

NO Will you obtain data through intervention or interaction with these individuals?

“Intervention” includes both physical procedures by which data are gathered (e.g., measurement of heart rate or venipuncture) and
manipulations of the participant or the participant's environment that are performed for research purposes. “Interaction” includes
communication or interpersonal contact between the investigator and participant (e.g., surveying or interviewing).

4.

YES

NO Will you obtain identifiable private information about these individuals?

"Private information" includes information about behavior that occurs in a context in which an individual can reasonably expect that no
observation or recording is taking place, or information provided for specific purposes which the individual can reasonably expect will not
be made public (e.g., a medical record or student record). "Identifiable" means that the identity of the participant may be ascertained by
the investigator or associated with the information (e.g., by name, code number, pattern of answers, etc.).
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5.

YES

NO Does the study present more than minimal risk to the participants?

"Minimal risk" means that the risks of harm or discomfort anticipated in the proposed research are not greater, considering probability and
magnitude, than those ordinarily encountered in daily life or during performance of routine physical or psychological examinations or tests.
Note that the concept of risk goes beyond physical risk and includes psychological, emotional, or behavioral risk as well as risks to
employability, economic well being, social standing, and risks of civil and criminal liability.

CERTIFICATIONS:
For James Madison University to obtain a Federal Wide Assurance (FWA) with the Office of Human Research Protection (OHRP), U.S.
Department of Health & Human Services, all research staff working with human participants must sign this form and receive training in ethical
guidelines and regulations. "Research staff" is defined as persons who have direct and substantive involvement in proposing, performing,
reviewing, or reporting research and includes students fulfilling these roles as well as their faculty advisors. The Office of Research Integrity
maintains a roster of all researchers who have completed training within the past three years.

Test module at ORI website http://www.jmu.edu/researchintegrity/irb/irbtraining.shtml
Name of Researcher(s) and Research Advisor

Training Completion Date

Jeremy D. Akers

05/04/17

Elizabeth S. Edwards

05/25/16

David L. Wenos

02/18/16

Trent A. Hargens

01/03/17

David Velky

09/02/16

Kristen Byrne

01/20/18

Brittany Rood

01/19/18

For additional training interests, or to access a Spanish version, visit the National Institutes of Health Protecting Human Research
Participants (PHRP) Course at: http://phrp.nihtraining.com/users/login.php.
By signing below, the Responsible Researcher(s), and the Faculty Advisor (if applicable), certifies that he/she is familiar with the ethical guidelines and
regulations regarding the protection of human research participants from research risks. In addition, he/she agrees to abide by all sponsor and university
policies and procedures in conducting the research. He/she further certifies that he/she has completed training regarding human participant research
ethics within the last three years.

_________________________________________
Principal Investigator Signature
_________________________________________
Principal Investigator Signature
_________________________________________
Principal Investigator Signature
_________________________________________
Principal Investigator Signature
_________________________________________
Principal Investigator Signature

________________
Date
________________
Date
________________
Date
________________
Date
________________
Date
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Submit an electronic version (in a Word document) of your ENTIRE protocol to researchintegrity@jmu.edu.
Provide a SIGNED hard copy of the Research Review Request Form to:
Office of Research Integrity, MSC 5738, 601 University Boulevard, Blue Ridge Hall, Third Floor, Room # 342
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Purpose and Objectives
Two out of three US adults are overweight or obese and prevalence in Virginia and Rockingham County are
comparable at almost 65% (CDC, 2015 Sentara RMH Community Health Needs Assessment). According to the
Healthy Community Council Community Stakeholder Survey Report, obesity is the top ranked health concern
in Harrisonburg, Rockingham County and surrounding areas, indicated by 71% of respondents. More than 35
obese Rockingham County residents undergo bariatric surgery at Sentara RMH Medical Center (SRMH) each
year. While the success rate for weight loss within this program in the first year is high (greater than 60%),
opportunities for enhancing behavior for long-term weight loss maintenance (WTLM) are needed. According
the SRMH Medical Center’s bariatric physician, local patients have expressed interest in supportive and
structured exercise programs following bariatric surgery. Post-operative physical activity is associated with
increased weight loss and weight loss maintenance (Egberts 2012).
Our research team is collaborating with SRMH to conduct a 12-week nutrition and exercise intervention
with their bariatric patients and overweight/obese non post-operative individuals. We recently submitted a
RMH Foundation Healthy Community Grant. Financial support received from the Foundations Grant will fund
the nutrition intervention. The objective of the nutrition intervention is increasing fruit and vegetable intake by
pairing food preparation with access to local fresh vegetables has not been studied with this population.
Potential financial support received from the CHBS Collaborative Grant will assist in exercise intervention that
is highlighted in this proposal. The proposed 12-week community-based intervention will include 6 weekly
vegetable workshops and expert guided exercise sessions three times per week for post-operative bariatric
patients and obese/overweight non post-operative individuals.
Procedures/Research Design/Methodology/Timeframe
Participants. Researchers will recruit adults who have undergone bariatric surgery within the past 6-24 months
and a non post-operative obese/overweight comparison. Exclusion criteria will include women who are
pregnant, orthopedic limitations that would limit their ability to complete the exercise intervention, or health
conditions that would place them at high risk according to ACSM guidelines.
Recruitment. Participants that meet inclusion criteria will be recruited through Facebook and personal contact
with the Bariatric Surgery Department at SRMH (Appendix L). Additionally, a bulk email will be sent out to the
JMU community (Appendix J). If participant population is low, the lead researcher will reach out to the
bariatric surgery clinics at Winchester Medical Center, UVA Medical Center, and Martha Jefferson Hospital to
inform staff of our research study.
Research Design. This study will be a 12-week trial with two groups Bariatric (BG) and Non post-operative
(NO). Both groups will participate in a High Intensity Interval Training (HIIT) and have the opportunity to
participate in the nutrition education intervention (Farmer’s Market, FM). Exercise training will occur on JMU’s
campus three times per week and 85% compliance will be required to remain in the study and receive study
incentives. There will be two cohorts with the NO starting testing in Fall 2017 and the BG starting January
2018. Clinical measures, including body composition and blood analyses, and fitness measures will be assessed
at baseline, midway, and post-intervention. Physical activity and dietary intake will be assessed at baseline, 34 weeks, 6-7 weeks, 9-10 weeks, and post-intervention. Successful completion of interventions and posttesting will be compensated with a new FitBit. Participants who participate in the Nutrition Intervention will
receive weekly $25 vouchers to the Harrisonburg Farmer’s Market.
Informed Consent & Data Collection. Men and women interested in participating in the study will have an
initial appointment with study personnel, where they will be informed of the study procedures and risks. Each
individual who consents to be in the study will complete the Informed Consent (Appendix A) and a Physical
Activity Readiness Questionnaire (PAR-Q) (Appendix B). If a participant responds “yes” to any of the questions
on the PAR-Q form they will be advised to seek physician approval prior to entrance in the study (Appendix F).
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After completing the informed consent the participant will be instructed to complete the Health Status
Questionnaire (Appendix C), PACES (Appendix D), 4-Day Food Intake Record (Appendix E), and Health Related
Quality of Life (Appendix G).

Clinical Measures
Blood Analysis
Chol
GLU
A1C
TNF-Alpha
Lp-PLA2
Blood Pressure
Body Comp
BF%
FFM
FM
BMD
CardioRes (Submax)
4 Day FIR
Perceived Enjoyment
7-day PA (activPAL)

15 Post-op Bariatric
Pts
6mo-2.5 yr Post-op
15 Nonoperative
obese/overweight
individuals

Training Measures
Calculated Kcal
Heart Rate
RPE

Assessment

30 Selected for Ex
Intervention

30 Participates in
FM/Behav

Pre Assessment:
Clinical Measures

Pre Assessment:
- F/V Screener
- Mindful Eating Quest.
-Self-efficacy
-Food Preferences
-Purchasing Practices

Grouped By Cohort

Fall 2017

Spring 2018

Weeks 1-2

5 min warmup
20 min @50%
5 min cool down

5 min warmup
20 min @50%
5 min cool down

Weeks 3-6

5 min warmup
4 x 1min @ 80%
4 x 4 min @ 50%
5 min cool down

5 min warmup
4 x 1min @ 80%
4 x 4 min @ 50%
5 min cool down

Week

6W Assessment:
Clinical Measures

Assessment
Week

Weeks 7-12

Assessment
Week

5 min warmup
6 x 1min @ 80%
5 x 3 min @ 50%
5 min cool down

5 min warmup
6 x 1min @ 80%
5 x 3 min @ 50%
5 min cool down

Post Assessment:
Clinical Measures

6 weeks:
-Weekly Nutrition Edu
-Weekly Cooking
Workshop
-$25 FM Prescriptions
Post Assessment:
- F/V Screener
- Mindful Eating Quest.
-Self-efficacy
-Food Preferences
-Purchasing Practices
6M Follow up Survey
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OUTCOME MEASURES (These measures will occur after initial meeting for pre/mid/post testing)
Blood Pressure. Blood pressure measurements will be taken using a sphygmomanometer. A blood pressure
cuff will be placed over the brachial artery of the right arm, slightly above the elbow. Pressure in the cuff will
be inflated to approximately 160 mmHg, and then deflated slowly to discern the systolic pressure (onset of
heart sounds) and diastolic pressure (cessation of heart sounds) using a stethoscope.
Blood Draws. A fasted (8-10 hour) blood sample will be obtained from each participant via venipuncture of
the antecubital vein during the second test session. All participants will have blood drawn by trained research
staff in the Health Assessment Lab. All proper blood borne pathogen protocols will be followed. Measures will
include:
a Blood glucose (FBG)
b Blood lipids
i Total cholesterol (TCHOL)
ii Low density lipoprotein cholesterol (LDL-C)
iii High density lipoprotein cholesterol (HDL-C)
iv Triglycerides (TRIG)
c Hemoglobin A1c (A1c)
d Tumor necrosis factor- alpha (TNF-alpha)
e Lipoprotein-associated phospholipase A2 (Lp-PLA2)
Health Status. (Questionnaire) Health status will be evaluated via questionnaire, as well as stratification using
the ACSM Risk Stratification for Cardiovascular Disease Risk (ACSM, 2010). This will be used to further screen
participants for medications, conditions, or injuries that may impact their ability to safely participate in
exercise.
Physical Fitness. Cardiovascular fitness will be assessed through a submaximal graded exercise test performed
on a treadmill. Oxygen consumption, blood pressure, heart rate and rating of perceived exertion (RPE) will be
monitored throughout the test. For each stage, grade and/or speed will be increased. HR, BP, and RPE will be
measured every three minutes. The protocol will continue until the participant reaches age-predicted maximal
heart rate, volitional fatigue, asks to stop, or experiences adverse signs or symptoms (ACSM, 2010). This
measure will be monitored by an ACSM Certified Clinical Exercise Physiologist. A CPR/First Aid trained research
member will be present at all sessions and have access to the Defibrillator.
Body Weight, Height, and Composition. Height and weight will be measured in a private setting in the lab. On
that same day, waist and hip circumference will be taken, in order to examine body fat distribution. Waist
circumference will be measured via a cloth tape measure at the narrowest point between the rib cage and hip
bone. Hip circumference will be measured at the widest point around the hips and gluteal muscles.
Dual-energy x-ray absorptiometry (DXA) will be used to estimate body composition data through the whole
body scan. Assessment will take place using the Norland DXA. The participant will be asked to lie on their
back, positioned on the machine according to protocol. They will be asked to lie completely still, while
breathing normally, and closing their eyes while the scan is in progress. The whole body scan lasts
approximately 10 minutes. The DXA analysis provides the most accurate method available to assess body
composition. Procedures and risks will be presented to each participant before each DXA scan.
Session Rating of Perceived Exertion (RPE): At the end of each training session, participants will be asked to
rate how the training session was on a scale of 1-10. The RPE scale is a numeric way of measuring physical
activity intensity level. Perceived exertion is how hard a subject feels like their body is working. It is based on
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the physical sensations a person experiences during physical activity, including increased heart rate, increased
respiration or breathing rate, increased sweating, and muscle fatigue. (Appendix I)
Perceived Enjoyment: Perceived enjoyment of physical activity will be assessed using the Physical Activity
Enjoyment Scale (PACES) (Appendix D)
Health Related Quality of Life (HRQoL): The 4-item CDC module on HRQoL will be administered at baseline,
mid-way, and post-testing to assess HRQoL. (Appendix G)
Physical Activity: Daily physical activity of life will be measured during the pre/mid/9 post testing as well as
weeks 3-4 and 9-10 by using activPALs for a seven-day period. These credit card sized accelerometers will be
worn for all waking hours and provide a quantitative measure to identify additional daily physical activities
participants are engaged in (walking, sleeping, structured activity, etc.)
Resting Metabolic Rate (RMR): RMR is the amount of energy required to maintain the body's normal
metabolic activity, such as respiration, maintenance of body temperature (thermogenesis), and digestion. A
fasted (8-10 hour) morning RMR measure will be obtained using the MedGem indirect calorimeter.
Participants will rest in a comfortable chair in a quiet environment. Participants will wear a nose clip and place
the single user mouthpiece (attached to the MedGem) comfortably in their mouth. Participants will breathe
normally and the test lasts approximately 10 minutes.
Food Intake: Food intake will be collected by using Food Intake Records (Appendix E). Participants will be
taught appropriate recording measures on the initial visiting by a Registered Dietitian. Participants will write
down all food and beverages consumed during a 4-day period (3 week days, 1 weekend).
The participants participating in the Nutrition Intervention will complete the following questionnaires. They
will complete pre/post**
NIH Eating at America’s Table Fruit and Vegetable Screener: The EATS F/V Screener has been used widely to
track changes in fruit and vegetable intake in specific population groups. The tool can be found here:
https://epi.grants.cancer.gov/diet/screeners/fruitveg/allday.pdf
Mindful Eating Questionnaire: The mindful eating questionnaire assesses physical and emotional sensations
associated with eating. The tool can be found here:
https://sharedresources.fredhutch.org/sites/default/files/MindfulEatingQSample.pdf
Diet Self Efficacy Scale (DIET-SE): This scale assesses scenario-based eating temptations for a range of

dieting situations. The tool can be found here:
http://www.midss.org/sites/default/files/diet_se_questionnaire.pdf
Food Preferences/Purchasing Practices: Assesses consumption, purchasing preferences, and individual and
purchasing patterns and practices of food and beverage. (Appendix K)
INTERVENTIONS:
Exercise Interventions: All participants will complete a 12-week training program of three days per week of
HIIT either in fall 2017 or spring 2018. Exercise will take place on a treadmill and incline will be adjusted to
minimize strike impact. All percentages are based on baseline heart rate measures (i.e. 50% of max heart rate).
Exercise intervention will include a 2-week run-in to minimize injuries. Exercise training will be supervised and
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will take place in Godwin Hall. A CPR/First Aid trained research member will be present at all sessions and
have access to the Defibrillator.

Weeks 1-2 (Run-in)

Weeks 3-6

Weeks 7-12

High Intensity Interval Training
5 min warmup
20 min @50%
5 min cool down
5 min warmup
4 x 1min @ 80%; 4 x 4 min @ 50%
5 min cool down
5 min warmup
6 x 1min @ 80%; 5 x 3 min @ 50%
5 min cool down

Nutrition Intervention:
Participants will be encouraged to participate in 6, 2-hour food experience workshops in the new JMU Health
and Behavioral Studies Foods Lab. For participant convenience, two identical workshops will be held biweekly
over the intervention for participants to engage in. Workshops will focus on up to three seasonal vegetables
and all participants will prepare a main entrée vegetable recipe at their own cooking station. Education will
include demonstrations and taste-tests of other methods of vegetable preparation. Dialogue of planning for
meal preparation and budget-friendly purchasing practices will be facilitated. Emphasis on local agriculture and
seasonality of produce will be included. Eating enjoyment and mindful eating tenets will be incorporated in the
eating experience concluding each workshop. All sessions will be supervised by a Registered Dietitian.
Participants will be compensated for their participation in the Nutrition Intervention by receiving weekly $25
Harrisonburg Farmer’s Market food vouchers (to be used specifically for fruits and vegetables, and will be
monitored by HFMA staff by specific food vouchers) after all workshops. Non-perishable food for recipes and
small kitchen tools (measuring cups and spoons, vegetable brush, etc.) will be offered at each workshop. SRMH
will be handling the funding for the HFMA food vouchers.
Questionnaires and surveys will be administered at the first and last workshop.
Time Required.
Outcomes Measures: Participants will be asked to commit to seven testing and informational sessions that will
each last up to 1.5 hours. Testing will take place as follows:
●

Familiarization: Upon expressing interest, participants will be asked to attend a familiarization
session. During this session, all tests and procedures will be explained and participants will complete
the appropriate health and medical status questionnaires and an Informed Consent Form. A copy of
the Informed Consent will be given to each participant. Additionally, participants will be asked to
complete the questionnaires pertaining physical activity levels, health behavior, and perceived
enjoyment. Participants will also be instructed on how to accurately complete a 4-day Food Intake
Record (three week days and one weekend day) and given hard copy forms to be completed and
returned to the researchers when completed. This session is estimated to last approximately 1 hour.
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●

Baseline, 6 weeks, 12 weeks Clinical Testing: Clinical testing will be conducted following an 8-10 hour
fast and will consist of a blood draw, measurement of blood pressure, and heart rate, RMR, and a DXA
scan for the assessment of body composition. Diet record will also be collected. This session is
estimated to last approximately 1.5 hours (70 minutes for testing, 20 minutes for dietary records). All
clinical testing will take place in the Health Sciences Human Assessment Lab.

●

Baseline, 6 weeks, 12 weeks Fitness Testing: Participants will be asked to come in on a separate day
to complete a volitional submaximal exercise test (VO2max test). Fitness testing will be completed in
Godwin Hall. This session is estimated to last approximately 30 minutes.

Exercise Training: Participants will be asked to commit to up to three hours per week, for twelve weeks for the
training segment of this project.


Training Protocol: Each participant (except FM) will participate in a training session three days per
week that will last 1 hour per session and will progress in intensity. These training sessions will be
completed in Godwin Hall. A CPR/First Aid trained research member will be present at all sessions and
have access to the Defibrillator.

Nutrition Intervention: Participants will be asked to commit to two hours weekly, for 6 weeks for the nutrition
intervention segment of this project.


Nutrition Sessions: Each participant will participate in 6 two hour nutrition education and cooking
workshops during the first 6 weeks of the exercise intervention (fall 2017 or spring 2018). These
workshops will be competed in the Health and Behavioral Studies Foods Lab.

Risks. There is minimal risk associated with submaximal exercise testing in individuals who are “low” or
“moderate” risk according to the ACSM (ACSM, 2013). There is a minimal level of discomfort due to muscle
soreness and fatigue that may be experienced during the exercise testing. Muscle soreness may be felt 24-48
hours following the testing.
The risks of venipuncture blood sampling include possible mild bruising and the risk of transfer of blood-borne
pathogens. This risk is considered to be minimal and all safety precautions for handing blood samples will be
followed according to OSHA protocols.
According to the manufacture’s specifications (i.e., Norland), whole body DXA analysis exposes participants to
0.2 microsieverts. The exposure to radiation during a single chest x-ray (i.e., 120 microsieverts) is more than
1000 times greater than radiation from the Norland DXA. Also, background radiation from DXA is about equal
to the amount of radiation one experiences eating a banana. Participants will be informed that effects of DXA
scans are cumulative and the risk is dependent upon their prior exposure to radiation. Procedures and risks
will be presented to each participant before each DXA scan.
Workshops will be held in a foods lab that incorporates known food allergens. Researchers will assess their
food allergies before workshops convene and remove allergen foods.
Benefits. Participants will receive the results from their own fitness testing, including comparison of age and
sex matched norms for each maximal oxygen test. Participants will also receive information regarding their
current risk for cardiovascular disease, body composition, and bone mineral density. During the training
sessions, participants will be receiving monitored workout sessions and motivation from researchers.
Additionally, participants who complete the study will be offered a dietary consultation.
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Participants who successfully complete the 12 week intervention (all three arms) will receive a FitBit.
Participants in the Nutrition Intervention will receive weekly $25 Harrisonburg Farmer’s Market fruit and
vegetable vouchers.
Where will the research be conducted?.
Testing: Human Assessment Lab, Burruss Hall
Training: Human Performance Lab / Marilyn Crawford Fitness Center, Godwin Hall (116/218)/ HBS Food Lab
Deception.
Deception will not be used.
Timeframe.
May 2017: IRB approval
June 2017: Recruitment of subjects; Beginning of exercise interventions/ initial for NO
Late July / Early August 2017: Mid-study measurements for nonoperative obese/overweight(6 weeks)
September 2017: Final measurements (12 weeks), Recruitment for BG participants
October 2017: Preliminary Data Analysis for presentation at regional and national conferences
January 2018 Beginning of exercise intervention/ initial measures for BG
February –June: Final data analysis, Manuscript/poster/presentation development
May-June: Manuscript submission
Data Analysis
For this study, the participants’ will be addressed by name but given a randomly assigned identification
number for analysis purposes. Name and identification number will be recorded in a separate file. Names are
important in addressing the participants when they are in the Human Performance Lab/Health Assessment Lab
as well as when contacting a participant about scheduling. Furthermore, names are necessary because until
the individual agrees to be a participant, the individual will not be assigned an identification number.
Information pertaining to name and identification number, informed consent form (this form requires the
participant’s signature), and data collection forms will all be kept in separate locked file cabinets containing
only this information. Data will be kept according to identification number, not name. No names will be used
in the publication of this study or in any other fashion pertaining to the presentation of the study. During the
data analysis, collective data only will be assessed. The hard copies of data (not including any information with
identifying information) will be kept in a locked filing cabinet in a locked office, and only research staff will
have access to these files. Additionally, electronic copies (Excel and SPSS formats) will be kept in the University
supported shared drive for the Human Performance Lab in Godwin, which will be password protected so that
only research staff are able to open the files.
The principal researchers will be the only individuals with access to the original data and identifying
information. This applies to both hard copies and electronic copies of this data. The information that connects
individual participants with their individual study data will be destroyed immediately after the completion of
the study or if the participant chooses to withdraw at any point. The hard copy of all data collected will be in
Microsoft Excel and SPSS formats and stored in a locked file cabinet. SPSS statistical software package will be
used for all data analysis.
Data will be analyzed using the SPSS 20.0 statistical software package. Statistics will consist of mixed-design
ANOVA (time x exercise condition), followed by post-hoc tests with a least squares difference correction
factor. Bivariate analyses and linear regressions will also be used to assess the relationships between
variables.
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At the end of the study, all information that matches up individual respondents with their answers will be
destroyed.
Reporting Procedures.
Participants will be provided health and fitness tests data at the completion of each test. No researcher will
deny a participant of any information related to his or her own test results. We will inform participants with
generalized results of the study, pertaining to which group had better results, and any recommendations for
continuing exercise.
The findings of the study will be presented at regional (SEACSM) and national (ACSM), Obesity Society
organizations conferences to an audience of health and wellness professionals, and submitted for publication
in professional journals.

Experience of the Researcher (and advisor, if student):
A Jeremy Akers, PhD, RD received his doctorate in Nutrition in Sports and Chronic Disease from Virginia Tech
in 2010. Jeremy is a Registered Dietitian with the Academy of Nutrition and Dietetics. His areas of interest
are behavioral therapies for long-term weight loss maintenance (WTLM) and chronic disease prevention,
and nutrition and physical activity. Jeremy served as the Obesity Prevention Dietitian for the Virginia
Department of Health, Division of WIC and Community Nutrition Services for almost four years. His job
involved developing community obesity prevention programs, managing health department grants,
obesity data collection and developing the Virginia Healthy Weight State Plan. He has taught courses in
nutrition for 12 years along with conducting numerous studies involving nutrition and physical activity.
B

Elizabeth Skidmore Edwards, Ph.D. received her doctorate in Exercise Physiology in 2011 from the
University of Miami. Dr. Edwards is an assistant professor in the Department of Kinesiology, as well as the
Executive Director of the Morrison-Bruce Center for the Promotion of Physical Activity for Girls and
Women. She has taught courses in exercise physiology for 10 years. In addition, she has conducted
numerous studies involving exercise testing and prescription across all ages at the University of Miami and
James Madison University.

C

Dr. David Wenos is a full professor and director of the Human Assessment Laboratory in the Department of
Health Sciences. He has conducted numerous related studies in the areas of body composition, exercise
intervention, and energy expenditure. He has collaborated in research studies, theses, and directed
research projects with faculty from both Health Sciences and Kinesiology. He teaches all of the physical
health assessments that are included in this study in three lab-based courses. He has served as a thesis
director on related research projects for 15 years.

D Trent A. Hargens, Ph.D. is an Assistant Professor of Exercise Physiology in JMU’s Dept of Kinesiology. Prior
to his appointment at JMU in August of 2011, he was an Assistant Professor of Exercise Science with the
Human Performance Laboratory at Ball State University from 2007 – 2011. He has published several peerreviewed articles in the field of clinical exercise physiology, exercise physiology, and in the area of sleep
disordered breathing. His primary research interests revolve around the physiological mechanisms that
link chronic diseases, with an emphasis on sleep disordered breathing and obesity.
E

David Velky is a graduate student in Kinesiology at James Madison University. He has assisted in research
studies prior to this and completed the two-course sequence in clinical exercise physiology within the
master’s program.
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F

Kristen Byrne is a graduate student in Health Sciences at James Madison University. She has assisted in
research studies prior to this and currently teaches curriculum related to exercise testing and prescription
at JMU.

G

Brittany Rood is a graduate student in Kinesiology at James Madison University. She has assisted in
research studies prior to this and currently teaches curriculum related to exercise testing and prescription
at JMU.
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Appendix A. Informed Consent
James Madison University
Departments of Kinesiology and Health Sciences
Consent for Investigative Procedure
(Informed Consent)
You are being asked to participate in a research study conducted by Drs. Elizabeth Edwards, Jeremy
Akers, Trent Hargens, David Wenos, and graduate student David Velky from the Departments of
Kinesiology and Health Sciences at James Madison University. The purpose of this study is to determine
how nutrition and exercise interventions help patients who have had bariatric surgery and non postopertaive obese/overweight individuals attain their health and wellness goals.
Research Procedures. The study will consist of a 12-week program. The research study will consist of
two cohorts; fall 2017 and spring 2018 groups. Each participant will be participate in an exercise
intervention for three days per week and have the opportunity to participate in a nutrition education
intervention. Prior to beginning the study, at the mid-point of the study (6-7 weeks), upon completion of
the study (13-14 weeks), you will complete various supervised tests and questionnaires to measure the
physical fitness, health status, lifestyle behaviors, body composition, blood lipids, insulin, and blood
glucose levels.
Note: In the event you discover that any of the following information is not clear, please ask one of
the researchers to explain immediately.
The study coordinator will go over each of these measures again before conducting the test.
Blood Pressure. Blood pressure measurements will be taken using a sphygmomanometer and
stethoscope. A blood pressure cuff will be placed over the upper portion of your right arm, slightly above
the elbow. The cuff will be inflated to approximately 200mmHg and then slowly released, while a
researcher uses a stethoscope to listen to sounds of blood flow through the vein on this inside of your
elbow.
Blood Draws. A fasted (8-10 hour) blood sample will be obtained by a butterfly needle in a vein in your
mid arm. All blood draws will be taken by trained personnel on-site at JMU. In order to minimize the
transfer of blood-borne pathogens, the trained person taking your blood will wear latex gloves at all times
during blood sampling and testing. For each blood draw, we will be measuring several different
substances in the blood related to health and disease risk.
Preparation for Blood Draw. You will be asked to fast for 8-10 hours before the session. This includes
coffee, tea, alcohol, or tobacco products.
Body Composition. Your height and weight will be measured and used to calculate body mass index BMI
(kg/m2). Additionally, the size of your waist and hips will be measured with a cloth tape measure. Your
waist measurement is important in determining your risk for cardiovascular disease and diabetes. Dualenergy x-ray absorptiometry (DXA) will be used to estimate body composition data through the whole
body scan. Wear clothing that is comfortable and free of metal. For the DXA scan, you’ll be asked to lie on
your back and remain still for the whole scan; the scan will last approximately 6-10 minutes.
Resting Metabolic Rate (RMR). The amount of energy required maintaining your body's normal
metabolic activity, such as respiration, maintenance of body temperature, and digestion will be measured.
A fasted (8-10 hour) morning RMR measure will be obtained. This test will take place sitting in a
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comfortable chair in a quiet environment. You will be required to wear a nose clip and place the single
user mouthpiece comfortably in their mouth. You will breathe normal into the RMR machine for
approximately 10 minutes.
Submaximal Exercise Test. The purpose of the submaximal graded exercise test, also known as a
submax VO2 test, is to measure cardiorespiratory fitness. Cardiorespiratory fitness is the ability to engage
in dynamic moderate- to high-intensity exercise for a prolonged period of time. Cardiorespiratory fitness
is an important consideration when health risks and overall exercise capability are assessed. High levels
of cardiorespiratory fitness are correlated with reduced risk coronary artery disease. A CPR/First Aid
trained research member will be present at all sessions and have access to the Defibrillator.
Preparation for Exercise Testing. Prior to exercise testing, we will ask you to not eat or drink anything,
except water for three hours prior to the test. Please note that this includes caffeinated beverages – such
as coffee or tea! Use of tobacco products should be avoided at least three hours prior to testing as well.
Please avoid heavy exercise on the testing day. Try to get to get at least six hours of sleep the night before,
to ensure that you are well rested. Wear clothing that is comfortable and allows you to move freely, such
as shorts, a t-shirt, and comfortable running shoes. Be aware that the test is fatiguing, so you may wish to
be fully hydrated before the test.
Procedure for Exercise Testing. Resting heart rate and blood pressure will be taken prior to testing.
The treadmill test follows a predetermined protocol to reach a predetermined heart rate at approximately
8% of your age-predicted maximum heart rate. You will walk or run on a treadmill, with the speed
and/or grade increasing as the test progresses, until you’re working as hard as you can. You will be fitted
with a heart rate monitor chest strap and a pulmonary facemask. Nonverbal cues will be used to
communicate during the test. Hand signals include “yes,” “no,” and/or “stop the test.” It is important to
realize that you may stop the test when you wish because of feelings of fatigue or any other discomfort.
Additionally, we may stop the test at any time due to signs of fatigue or abnormal physiological responses.
These may include failure for heart rate increase with increased workload, dizziness, chest pains, or
muscular fatigue. Please note that both protocols and procedures are in adherence with the guidelines set
forth by the American College of Sports Medicine for exercise testing.
You will be permitted to leave once post exercise heart rate drops below 100 beats per minute or resting
heart rate levels. Avoid a hot shower and a heavy meal for at least an hour after the exercise test.
Health Status. Your health status will be determined via questionnaires and ACSM’s Risk Stratification
for Cardiovascular Disease Risk (ACSM, 2010). Assessment of your risk for cardiovascular disease will be
made using the ACSM’s Coronary Artery Disease Risk Factor Thresholds along with the ACSM Risk
Stratification. Risk stratification is based upon age, family history, smoking habits, blood lipid levels, and
fasted blood glucose values, resting blood pressure, body mass index and physical activity habits. We will
also be asking about current and previous conditions, surgeries, and medications, so that we may ensure
that you are healthy enough to participate in this study.
Lifestyle Behaviors
Physical Activity: For one week at the beginning, weeks 3-4, middle, weeks 9-10, and end of the
intervention, you will be asked to wear an accelerometer during all of your waking hours. This device is
about the size of credit card and sticks directly to your thigh and can be worn in the shower. This device
will track how much you move throughout the day.
Additionally, you will be asked to complete the following questionnaires:
a. Perceived Enjoyment– The Physical Activity Enjoyment Scale (PACES) asks you about your perceptions
and feelings about physical activity.
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b. Dietary Behavior –A 4-day dietary record, where you will record what you consumed for 4
nonconsecutive days (3 week days and 1 weekend day).
d. Health Related Quality of Life- The Health Related Quality of Life Scale is a measure of a person’s
physical and mental health and function.
Time Required. You will be asked to commit to up to three hours per week, for the twelve weeks for the
training segment of this project. If you choose to participate in the Nutrition Intervention you will be
asked to commit an additional two hours every week, for the first 6 weeks of your cohort. Additionally,
you will be asked to commit to seven testing and informational sessions that will each last up to two
hours. Testing and training will take place as follows:
●

Familiarization Session (Pre): This is the familiarization session. During this session, all tests and
procedures will be explained, after which we’ll ask you to complete the appropriate health and
medical status questionnaires and an Informed Consent Form. Additionally, participants will be
asked to complete the questionnaires pertaining physical activity levels, health behavior, sleepiness,
and perceived enjoyment. This session is estimated to last approximately 1 hour. You will also be
given dietary record forms to be completed and returned to the researchers at the next meeting. After
this session, future questionnaires will be completed during the clinical testing sessions.

●

Clinical Testing (Pre, Mid, Post): Clinical testing will be conducted following an 8-10 hour fast and
will consist of a blood draw, measurement of blood pressure, and heart rate, RMR, and a DXA scan for
the assessment of body composition. Diet record will also be collected. This session is estimated to
last approximately 1.5 hours (70 minutes for testing, 20 minutes for dietary records). For the midpoint, post-training, follow-up sessions, you will also be asked to complete the study questionnaires at
this session. This is expected to add approximately 15 minutes to the session. All clinical testing will
take place in the Health Sciences Human Assessment Lab in Burruss Hall.



Fitness Testing (Pre, Mid, Post): Participants will be asked to come in on a separate day to complete
a volitional submaximal exercise test (VO2max test). Fitness testing will be completed in the
Kinesiology Lab in Godwin Hall. This session is estimated to last approximately 30 minutes. A
CPR/First Aid trained research member will be present at all sessions and have access to the
Defibrillator.



Exercise intervention: in addition to clinical testing, you will participate in a training session three
days per week. Training sessions will progress in intensity throughout the intervention, but will
always be 30 minutes long for the next 12 weeks. In brief, you will be participating in a short highintensity interval training, which consists of short bouts (1 minute) of high intensity exercise followed
by longer recovery periods (3-4 minutes). You will be asked to come to Godwin Hall to complete all
training sessions. Training groups are expected to see improvements in fitness. A CPR/First Aid
trained research member will be present at all sessions and have access to the Defibrillator.

●

Nutrition intervention: in addition to clinical testing, you will participate in weekly two hour
nutrition education and cooking workshops for 6 weeks. There will be a total of 6 workshops.
Workshops will focus on up to three seasonal vegetables and you will prepare a main entrée
vegetable recipe at your own cooking station. Education will include demonstrations and taste-tests
of other methods of vegetable preparation. Dialogue of planning for meal preparation and budgetfriendly purchasing practices will be facilitated. Emphasis on local agriculture and seasonality of
produce will be included. All workshops will be held in the Health and Behavioral Studies Building
Foods Lab.
● Additionally, you will be asked to complete the following questionnaires (Pre/Post):
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●
●
●

NIH Eating at America’s Table Fruit and Vegetable Screener: Track changes in fruit and
vegetable intake in specific population groups.
Mindful Eating Questionnaire: Assesses physical and emotional sensations associated with
eating.
Diet Self Efficacy Scale: Assesses scenario-based eating temptations for a range of dieting

situations.
●

Food Preferences/Purchasing Practices: Assesses consumption, purchasing preferences,
and individual and purchasing patterns and practices of food and beverage.

Risks. There is minimal risk associated with submaximal exercise testing in individuals who are “low” or
“moderate” risk according to guidelines established by the American College of Sports Medicine. There is
a minimal level of discomfort that may be experienced during the exercise testing, which includes muscle
soreness and fatigue. Muscle soreness may be felt 24-48 hours following the testing.
The risks of venipuncture blood sampling include possible mild bruising and the risk of transfer of bloodborne pathogens. This risk is considered to be minimal and all safety precautions for handing blood
samples will be followed according to OSHA protocols and SRMH.
According to the manufacture’s specifications (i.e., Norland), whole body DXA analysis exposes
participants to 0.2 microsieverts. The exposure to radiation during a single chest x-ray (i.e., 120
microsieverts) is more than 1000 times greater than radiation from the Norland DXA. Also, background
radiation from DXA is about equal to the amount of radiation one experiences eating a banana.
Workshops will be held in a foods lab that incorporates known food allergens. Researchers will assess
your food allergies before workshops convene and remove allergen foods.
Benefits. If you complete at least 85% of the sessions associated with your assigned group, as well as all
testing at baseline, midway, and post-intervention, you will receive a new Fitbit to keep.
Additionally, you will receive free testing of cardiorespiratory fitness, body composition, lipid profile, and
bone mineral density. You will receive the results from your individual tests, including a rating of how
you compare to individuals within your age category. Along with these results, you’ll receive information
regarding the importance and meaning of measure, as well as what steps you could take to improve these
measures if you would like to. You will also have the opportunity to learn about habitual dietary intake
and your percentages of energy nutrients and total caloric intake.
If you participate in the nutrition education, you will receive $25 vouchers to buy fresh fruits and
vegetables at the Harrisonburg Farmer’s Market as well as targeted information on how to maximize your
health through nutrition.
During the exercise intervention you will receive free monitored workout sessions and motivation from
the researchers. The researchers expect to see positive metabolic changes for participants in all training
protocols that may result in improved health and general well-being.
Confidentiality. All data and results will be kept confidential. You will be assigned an identification code.
All of your questionnaires and other results will be filed only according to your identification code, with
your full name not located in that file. For the duration of the study, your first name will be stored with
this data, so that research staff may address you, but this will be removed at the completion of the study.
These results will be stored in a locked cabinet in a locked office. Electronic copies of the data will be
password protected and kept only on secure servers. Only research personnel, who may include
students, will have access to this data in either hard or electronic format. Any forms that link your name
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with your identification number, including this form, will be kept in a different file, which will be located
in the office of one of the head researchers on this study. Additionally, any electronic formats of this
information will be kept by one of the head researchers and will be password protected with a different
password than the data. None of your test results or data will be located in this file. Access to these files
will be limited to the head researchers on this staff and will only be used for the purposes of matching up
your data to previous results and to contact you for the follow-up measures. After the second follow-up
measure, any form that links your name to your identification number will be destroyed. The data
collected will be analyzed and used to complete three graduate student research theses, a national
presentation, and submission for publication in a professional journal.
Participation and Withdrawal. Your participation is entirely voluntary. You are free to choose not to
participate. Should you choose to participate, you can withdraw at any time without consequences of any
kind. If at any time you choose to withdraw from the study, any identifying information that links your
name to your data will be destroyed at that time.
Reporting Procedures. You will be provided health and fitness tests data at the completion of each test
and will receive the results of your blood tests after they have been processed. The findings of the study
will be presented at regional and national organizations conferences and submitted for publication in
professional journals.
Questions about the Study. If you have questions or concerns during the time of your participation in
this study, or after its completion or you would like to receive a copy of the final aggregate results of this
study, please contact:
Dr. Elizabeth Skidmore Edwards
Department of Kinesiology
James Madison University
edwardes@jmu.edu
540-568-5220

Dr. Jeremy D. Akers, RDN
Department of Health Sciences
James Madison University
akersjd@jmu.edu
540-568-8974

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
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Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in this
study. I freely consent to participate. I have been given satisfactory answers to my questions. The
investigator provided me with a copy of this form. I certify that I am at least 18 years of age.
____________________________________
Name of Participant (Printed)
______________________________________ ______________
Name of Participant (Signed)
Date
____________________________________
Name of Researcher (Printed)
______________________________________ ______________
Name of Researcher (Signed)
Date
Demographic Information
Full Name:

Nickname:

ID# ___________________ (Research personnel use)
Address:

__________________________
________________________________

Preferred phone:

______ Is this your: ☐ Work

Email address: ____________________________

Date of Birth:

☐ Home

☐ Cell

☐ Other: ________
(Month/ Day/ Year)

Optional Additional Consent
I understand that new risk factors are constantly emerging and that further analysis of my blood samples,
beyond those tests outlined in this consent form may provide valuable information. I consent to having
my blood samples stored indefinitely, so that they may be used in future analyses. If my blood is used in
these tests and yields information that would be pertinent to my health, the research team will attempt to
contact me to give me these results.
______________________________________
Name of Participant (Printed)
______________________________________ ______________
Name of Participant (Signed)
Date
____________________________________
Name of Researcher (Printed)
______________________________________ ______________
Name of Researcher (Signed)
Date

48
Appendix B. Physical Activity Readiness Questionnaire (PAR-Q)
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Appendix C. Health Status Questionnaire

Health Status Questionnaire

Part I Medical History
1. Has anyone in your family had a heart attack, heart surgery, or sudden death due to cardiovascular disease prior
to the age of 65? (Circle one)
Yes
No
If yes, who? _________________
How old were they? (Circle one)
2. Date of last medical exam: ________________

54 or younger

55-59

60-64

Last physical fitness test: _______________

3. Please list any operations that you have had: _____________________________________________________________________
____________________________________________________________________________________________________________
____________________________________________________________________________________________________________
4. Please list any condition for which you have been diagnosed or are being treated for by a physician or health
professional: ____________________________________________________________________________________________________________
____________________________________________________________________________________________________________
5. Please list all medications taken in the last six months: _____________________________________________________________
___________________________________________________________________________________________________________
___________________________________________________________________________________________________________
6. The occurrence of any of these health symptoms frequently is the basis for medical attention. Please check how
often you have each of the following:

Symptom

Cough up blood
Abdominal pain
Low back pain
Leg pain
Arm or shoulder pain
Chest pain
Swollen joints
Feel faint

1
Rarely

2
Infrequentl
y

3
Sometimes

4
Fairly
Often

5
Very Often

50
Dizziness
Breathless on slight exertion
7. Do you smoke? (Circle one)

Yes

No

If yes, how many per day: Cigarettes:
40 or more
20-39
10-19
1-9
Cigars or pipes only:
5 or more or any inhaled less than 5, none inhaled

Adapted from: Howley and Franks. (1992). Health Fitness Instructor’s Handbook. Health Status Questionnaire.
Champaign :Human Kinetics.
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Appendix D. PACES

When I am physically
active:

Disagree
a lot

No
opinion

Agree a
lot

1

I enjoy it

□

□

□

□

□

□

□

2

I feel bored

□

□

□

□

□

□

□

3

I dislike it

□

□

□

□

□

□

□

4

I find it pleasurable
(same as 1)

□

□

□

□

□

□

□

Disagree
a lot

No
opinion

Agree a
lot

5

It’s no fun at all

□

□

□

□

□

□

□

6

It gives me energy

□

□

□

□

□

□

□

7

It makes me sad

□

□

□

□

□

□

□

8

It’s very pleasant/fun

□

□

□

□

□

□

□

Disagree
a lot
9

My body feels good

□

No
opinion

□

□

□

Agree a
lot

□

□

□
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10 I get something out of it

□

□

□

□

□

□

□

11 It’s very exciting

□

□

□

□

□

□

□

12 It frustrates me

□

□

□

□

□

□

□

Disagree
a lot

No
opinion

Agree a
lot

13 It’s not at all interesting

□

□

□

□

□

14 It gives me a strong

□

□

□

□

□

15 It feels good

□

□

□

□

□

16 I feel as though I would

□

□

□

□

□

feeling of success

rather be doing
something else

□

□

□

□

□

□

□

□
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Appendix E. Food Intake Record
Four Day Food Intake Record Instructions
●

Please keep your record for four days on the forms provided.

●

The days should include three weekdays and one weekend day.

●

Select days that will most closely resemble your eating habits.

●

This record should include all meals, snacks, and beverages including water and cocktails. Anything
you put in your mouth should be listed.

●

If possible, weigh and/or measure your food before you eat it.

●

Record what you eat and drink as soon as you can to reduce the chance of forgetting. Be as specific as
possible by writing down brand names, food preparation methods and anything added to the foods
such as condiments, spices and other seasonings.

●

Also record the time you consume each food and the meal (i.e. Breakfast, snack etc.).

●

Your food intake will be analyzed using Nutrition Data for System Research software in the Sensory
and Diet Evaluation Lab.
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Subject ID Number ______________ Date ______________
Day (circle): 1 2 3 4

Time

Place

Page ___ of ___
Food Intake Record

Food Description
(Please specify, if known: brand names, cooking method, type of
product, and include labels when possible)

Portion
Size : How
many?

Portion
Size : Food
Model

Comments
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Appendix F. Physician Approval Form

Physician Approval Form

Patient Name: ___________________
1. Are there specific concerns or conditions we should be aware of before this
individual engages in the physical fitness assessment for this study??
______________________________________________________________________________
______________________________________________________________________________
2. If this individual has completed a graded exercise test (stress test) please provide
the following:
a. Date of Test: __________________________________________________________
b. A copy of the final exercise report and interpretation.

3. Please provide the following information so that we may contact you if we have
any further questions:
____ I AGREE to the participation of this individual in the herein described study.
____ I DO NOT AGREE that this individual is a candidate for this study.

Physician’s Signature

____________________________________________________

Physician’s name (printed) ____________________________________________________
Address

____________________________________________________
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Appendix G: Health Related Quality of Life

Health Related Quality of Life

File # __________

Healthy Days Core Module (CDC HRQOL-4)
1. Would you say that in general your health is:
1. Excellent
2. Very good
3. Good
4. Fair
5. Poor
6. Don't know
7. Refuse to answer
2. Now thinking about your physical health, which includes physical illness and
injury, for how many days during the past 30 days was your physical health not
good?
1. Number of days _____
2. None
3. Don't know
4. Refuse to answer
3. Now thinking about your mental health, which includes stress, depression, and
problems with emotions, for how many days during the past 30 days was your
mental health not good?
1. Number of days _____
2. None
3. Don't know
4. Refuse to answer
4. During the past 30 days, for about how many days did poor physical or mental
health keep you from doing your usual activities, such as self-care, work, or
recreation?
1. Number of days _____
2. None
3. Don't know
4. Refuse to answer
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Appendix H: Sentara Rockingham

Memorial Hospital Site Lett
Appendix I: Rating of Perceived Exertion
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Appendix J: JMU Bulk Email
Do you want to maintain that weight you worked so hard to lose? Do you want to learn
more about healthy living and reducing your risk of chronic disease? Do you want to receive
FREE personal training in a small group fitness environment? Do you want free cooking
classes? If the answer is yes, then join us today! Starting in June, JMU Departments of Health
Science and Kinesiology are partnering with Sentara RMH Bariatric Surgery for a research
study examining the physiological and psychological effects of low-volume, high-intensity
interval training in individuals 6 month- 2 years post-operative bariatric surgery. We are
also including 6 cooking workshops that include weekly $25 vouchers for the Harrisonburg
Farmer’s Market. There are no registration fees or costs and completers will receive a new
FitBit.
What is involved:
12-weeks of FREE training sessions with motivational exercise experts; FREE blood, nutrition,
cardiovascular, and body composition analysis; and dietary counseling upon request. FREE
cooking courses and nutrition education. (Would cost you thousands in a private clinic)
If you are interested please contact the research coordinator:
JMUbariatricstudy@gmail.com
(540) 568-2324
IRB No: XX-XXXX
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Appendix K: Food Preferences/Purchasing Practices:

Open-ended Items
1. How many times in the past week did you cook vegetables at home?
2. How many times in the past week did you make a meal with fresh vegetables at
home?
3. How many times in the past week did you make a meal with canned vegetables
at home?
4. How many times in the past week did you make a meal with frozen vegetables at
home?
5. How many times in the past week did you prepare a meal using a box mix (such
as Hamburger Helper, Zatarain's, macaroni and cheese or other food from a box
or other ‘meal in a minute’ type products)?
6. How many times in the last 30 days did you shop for vegetables at a grocery
store?
7. How many times in the last 30 days did you shop for vegetables at a
convenience store (such as a gas station, chain discount store, or drug store)?
8. How many times in the last 30 days did you shop for vegetables at a farmer’s
market?
Add logic:
[No shopping at farmer’s market:]
Why don’t you shop at a farmer’s market?
 No SNAP program/EBT accepted
 No credit/debit accepted
 Market days and hours are not convenient
 I get what I need from other places
 Food is too expensive
 Other

[Yes, shopping at a farmer’s market]
Why do you shop at a farmer’s market?






To support local farmers
Fresher produce
Better prices
Variety of products
Other

1. In the past week, which of the following fresh vegetables did you eat? (check all
that apply)








avocado
bell peppers
bok choy
broccoli
cauliflower
carrots
celery
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corn
cucumber
eggplant
iceberg lettuce
green beans
onion
potatoes
sweet potatoes
radishes
spinach
tomato
yellow squash
zucchini
other:______

2. In the past week, which of the following frozen or canned vegetables did you eat?
(check all that apply)






















avocado
bell peppers
bok choy
broccoli
cauliflower
carrots
celery
corn
cucumber
eggplant
iceberg lettuce
green beans
onion
potatoes
sweet potatoes
radishes
spinach
tomato
yellow squash
zucchini
other:______
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Appendix L: Facebook Post:
Dr. Garwood and Lemma are partnering with JMU to assist you with your post-operative
weight maintenance. You will have the opportunity to either receive FREE personal training
in a small group fitness environment or free cooking classes. We are conducting a research
study to examine the physiological and psychological effects of low-volume, high-intensity
interval training and 6 cooking /nutrition workshops that include weekly $25 vouchers for
the Harrisonburg Farmer’s Market. There are no registration fees or costs and completers
will receive a new FitBit. If you are interested you will receive 12-weeks of FREE training
sessions with motivational exercise experts; FREE blood, nutrition, cardiovascular, and body
composition analysis; and dietary counseling upon request. FREE cooking courses and
nutrition education. (Would cost you thousands in a private clinic)
If you are interested please contact: JMUbariatricstudy@gmail.com ; (540) 568-2324 IRB
No: XX-XXXX.
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